Why Arafura, Core Lithium, Mayne Pharma, and Newcrest shares are storming higher

A couple are shocked and elated at the good news they've just seen on their devices.

A couple are shocked and elated at the good news they've just seen on their devices.

The S&P/ASX 200 Index (ASX: XJO) is back from the Easter break with a bang. In afternoon trade, the benchmark index is up 1.3% to 7,312.2 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are storming higher:

Arafura Rare Earths Ltd (ASX: ARU)

The Arafura share price is up 6% to 50.8 cents. Investors have been buying this rare earths developer’s shares after it announced a binding offtake agreement with Siemens Gamesa Renewable Energy. The wind industry leader has signed an agreement for up to 400 tonnes per annum (tpa) of neodymium and praseodymium (NdPr) metal from the Nolans project.

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is up 3.5% to 90 cents. This is despite there being no news out of the lithium miner. However, it is worth noting that a number of ASX lithium shares are charging higher on Tuesday. This follows a decent night of trade for lithium stocks on Wall Street.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price is up 4.5% to $4.16. This follows news that the pharmaceutical company has completed the sale of its US generics portfolio. According to the release, Mayne Pharma has received US$90 million (~A$134 million) for the portfolio of commercial, pipeline, and approved non-marketed products. The agreement also includes a 10-year supply agreement for certain products and provides for up to US$15 million (~A$22 million) in contingent milestone payments.

Newcrest Mining Ltd (ASX: NCM)

The Newcrest share price is up 5% to $29.74. This morning, this gold miner revealed that it has received an improved takeover offer from North American peer Newmont Mining. Newmont has made an offer of $32.87 per share, which is up from its last offer of $27.40. This has been enough to get the Newcrest board to grant due diligence access.

The post Why Arafura, Core Lithium, Mayne Pharma, and Newcrest shares are storming higher appeared first on The Motley Fool Australia.

FREE Beginners Investing Guide

Despite what some people may say – we believe investing in shares doesn’t have to be overwhelming or complicated…

For over a decade, we’ve been helping everyday Aussies get started on their journey.

And to help even more people cut through some of the confusion “experts’” seem to want to perpetuate – we’ve created a brand-new “how to” guide.

Yes, Claim my FREE copy!
*Returns as of April 3 2023

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/JB4Gsnl

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *